Literature DB >> 29949805

18F-FDOPA PET/CT Uptake Parameters Correlate with Catecholamine Secretion in Human Pheochromocytomas.

Sophie Moog1,2, Sébastien Houy2, Elodie Chevalier3, Stéphane Ory2, Georges Weryha1, Marion Rame2, Marc Klein1, Laurent Brunaud4, Stéphane Gasman2, Thomas Cuny5.   

Abstract

BACKGROUND: 18F-FDOPA positron emission tomography/computed tomography (PET/CT) is a sensitive nuclear imaging technology for the diagnosis of pheochromocytomas (PHEO). However, its utility in determining predictive factors for the secretion of catecholamines remains poorly studied.
METHODS: Thirty-nine histologically confirmed PHEO were included in this retrospective single-center study. Patients underwent 18F-FDOPA PET/CT before surgery, with an evaluation of several uptake parameters (standardized uptake values [SUVmax and SUVmean] and the metabolic burden [MB] calculated as follows: MB = SUVmean × tumor volume) and measurement of plasma and/or urinary metanephrine (MN), normetanephrine (NM), and chromogranin A. Thirty-five patients were screened for germline mutations in the RET, SDHx, and VHL genes. Once resected, primary cultures of 5 PHEO were used for real-time measurement of catecholamine release by carbon fiber amperometry.
RESULTS: The MB of the PHEO positively correlated with 24-h urinary excretion of NM (r = 0.64, p < 0.0001), MN (r = 0.49, p = 0.002), combined MN and NM (r = 0.75, p < 0.0001), and eventually plasma free levels of NM (r = 0.55, p = 0.006). In the mutated patients (3 SDHD, 2 SDHB, 3 NF1, 1 VHL, and 3 RET), a similar correlation was observed between MB and 24-h urinary combined MN and NM (r = 0.86, p = 0.0012). For the first time, we demonstrate a positive correlation between the PHEO-to-liver SUVmax ratio and the mean number of secretory granule fusion events of the corresponding PHEO cells revealed by amperometric spikes (p = 0.01).
CONCLUSION: While the 18F-FDOPA PET/CT MB of PHEO strongly correlates with the concentration of MN, amperometric recordings suggest that 18F-FDOPA uptake could be enhanced by overactivity of catecholamine exocytosis.
© 2018 S. Karger AG, Basel.

Entities:  

Keywords:  18F-FDOPA PET/CT; Catecholamine; Chromaffin cells; Endocrine tumor; Exocytosis; Pheochromocytoma

Mesh:

Substances:

Year:  2018        PMID: 29949805     DOI: 10.1159/000491578

Source DB:  PubMed          Journal:  Neuroendocrinology        ISSN: 0028-3835            Impact factor:   4.914


  4 in total

1.  Elevated 131I-MIBG activity in adrenocortical adenoma-what other imaging options do we have?

Authors:  Xiaotian Xia; Keshan Wang; Fuqiang Shao; Fan Hu; Shengqing Hu; Yu Dai; Yongxue Zhang; Xiaoli Lan
Journal:  Quant Imaging Med Surg       Date:  2022-04

2.  18F-FDG-PET/CT Evaluation of Indeterminate Adrenal Masses in Noncancer Patients.

Authors:  Xin He; Elaine M Caoili; Anca M Avram; Barbra S Miller; Tobias Else
Journal:  J Clin Endocrinol Metab       Date:  2021-04-23       Impact factor: 5.958

3.  Exploring the link between tumour metabolism and succinate dehydrogenase deficiency: A 18 F-FDOPA PET/CT study in head and neck paragangliomas.

Authors:  Thibaut Reichert; Nicolas Fakhry; Jean-Pierre Lavieille; Vincent Amodru; Frédéric Sebag; Pauline Romanet; Anderson Loundou; Frédéric Castinetti; Karel Pacak; Marion Montava; David Taïeb
Journal:  Clin Endocrinol (Oxf)       Date:  2019-10-01       Impact factor: 3.523

4.  Utility of 123I-MIBG Standardized Uptake Value in Patients with Refractory Pheochromocytoma and Paraganglioma.

Authors:  Hiroshi Wakabayashi; Tahahiro Konishi; Hiroto Yoneyama; Anri Inaki; Tomo Hiromasa; Takafumi Yamase; Norihito Akatani; Satoru Watanabe; Hiroshi Mori; Daiki Kayano; Seigo Kinuya
Journal:  Asia Ocean J Nucl Med Biol       Date:  2019
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.